Pdt Partners, LLC Generation Bio Co. Transaction History

Pdt Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.65 - $6.9 $8,789 - $16,615	-2,408 Reduced 10.85%	19,779 $74,000
Q2 2023 Aug 14, 2023	SELL	$3.5 - $5.67 $29,690 - $48,098	-8,483 Reduced 27.66%	22,187 $122,000
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $58,157 - $112,931	16,110 Added 110.65%	30,670 $131,000
Q4 2022 Feb 14, 2023	SELL	$3.66 - $6.77 $95,332 - $176,338	-26,047 Reduced 64.14%	14,560 $57,000
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $82,166 - $146,425	-17,557 Reduced 30.19%	40,607 $216,000
Q2 2022 Aug 15, 2022	SELL	$4.87 - $9.41 $182,386 - $352,413	-37,451 Reduced 39.17%	58,164 $382,000
Q1 2022 May 16, 2022	BUY	$4.16 - $7.76 $244,491 - $456,070	58,772 Added 159.52%	95,615 $702,000
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $220,689 - $919,969	36,843 New	36,843 $261,000
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.43 $252,880 - $346,824	-12,644 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$24.34 - $38.34 $307,754 - $484,770	12,644 New	12,644 $340,000

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.